Margination of Micro- and Nano-Particles in Blood Flow and its Effect on the Efficiency of Drug Delivery by Müller, K et al.
4th Micro and Nano Flows Conference
UCL, London, UK, 7-10 Semptember 2014
Margination of Micro- and Nano-Particles in Blood Flow and its Effect on the
Efficiency of Drug Delivery
Kathrin MU¨LLER1, Dmitry A. FEDOSOV1*, Gerhard GOMPPER1
1: Theoretical Soft Matter and Biophysics, Institute of Complex Systems and Institute for Advanced
Simulation, Forschungszentrum Ju¨lich, 52425 Ju¨lich, Germany
* Corresponding author: Tel.: +49 (0)2461 612972; Fax: +49 (0)2461 613180; Email:
d.fedosov@fz-juelich.de
Abstract Drug delivery by various micro- and nano-carriers offers the possibility of controlled transport
of pharmaceuticals to targeted sites (e.g., cancerous tissue). Even though the fabrication of carriers of
different sizes and shapes with a number of functionalities has made much progress in the last decade, their
delivery including controlled particle distribution and adhesion within the body remains a great challenge.
The adhesion of micro- and nano-carriers in blood flow is strongly affected by their distribution within the
vessel cross-section. To investigate the adhesion potential of carriers of different shapes and sizes, we employ
mesoscopic hydrodynamic simulations of blood flow in order to predict margination of carriers or their
migration properties toward vessel walls. The margination of carriers is studied for a wide range of hematocrit
values, and flow rates, using a two-dimensional blood-flow model. Two different particle shapes (spherical and
ellipsoidal) and various sizes, ranging from about hundred nanometers to several micrometers, are considered.
We find that the margination properties of particles worsen with decreasing carrier size. Spherical particles
yield slightly better margination than ellipsoidal particles; however, adhesion of ellipsoidal carriers is expected
to be superior due to a larger area for adhesive interactions. As a conclusion, micron-size ellipsoidal particles
seem to be favorable for drug delivery in comparison to sub-micron particles and spherically shaped carriers.
Keywords: Red Blood Cell, Drug Carrier, Flow Migration, Margination Probability, Particle Distribution,
Dissipative Particle Dynamics
1 Introduction
The use of micro- and nano-carriers for targeted
drug delivery provides promising strategies
for the treatment of various diseases such as
cancer (Ferrari, 2005; Jain and Stylianopoulos,
2010). However, design and physical de-
livery of the particles carrying different con-
trast agents and drugs are very challenging
tasks. Several important aspects in the fab-
rication process have to be taken into ac-
count, including bio-compatibility, durabil-
ity, binding to specific targets, and the abil-
ity of controlled release. Even though
micro- and nano-particle fabrication has been
strongly advanced in recent years (Duncan,
2006; Rolland et al., 2005; Davis et al., 2008;
Blanco et al., 2011), the delivery of carriers
to targeted sites is still poorly understood
(Jain and Stylianopoulos, 2010; Sanhai et al.,
2008; Huang et al., 2010). Determination of
the distribution of micro- and nano-carriers in
the organism following systemic administration
has been named as one of the several chal-
lenges in nanomedicine (Sanhai et al., 2008).
The other challenge for drug delivery is often
called biological barriers (Jain, 1989), which
include particle transport through microvascu-
lar walls, interstitial space, and cell membranes
(Jain and Stylianopoulos, 2010; Sanhai et al.,
2008).
The first step in the delivery of small carriers
is their transport along blood vessels which
determines their initial distribution. Further,
the distribution of micro- and nano-particles
is affected by their binding to specific targeted
sites. However, efficient binding of carriers
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can be achieved only if they are present near
vessel walls at sufficiently high concentra-
tions, and thus, the distribution of micro- and
nano-carriers within vessel cross-sections plays
an essential role in their efficient delivery.
The cross-sectional distribution of micro-
and nano-particles depends on local blood
flow properties such as hematocrit (volume
fraction of red blood cells) and flow rate as
well as on the particle characteristics such
as their size, shape, and deformability. The
migration of various suspended particles to-
ward walls in blood flow, which is also often
referred to as margination, has been observed
for white blood cells (Bagge and Karlsson,
1980; Goldsmith and Spain, 1984;
Fedosov and Gompper, 2014), platelets
(Tangelder et al., 1985; Woldhuis et al., 1992),
and rigid micro-particles (Tilles and Eckstein,
1987; Eckstein et al., 1988). Particle margina-
tion in blood flow is mediated by red blood cells
(RBCs), which migrate to the vessel center
(Goldsmith et al., 1989) due to hydrodynamic
interactions with the walls (called lift force)
(Cantat and Misbah, 1999; Abkarian et al.,
2002; Messlinger et al., 2009), and lead to an
increased concentration of different particles
within the RBC-free layer (RBCFL) near a
wall (a layer void of RBCs). More precisely,
the margination mechanism is a consequence
of the competition between lift forces on RBCs
and suspended particles, and their interactions
in flow (Kumar and Graham, 2012). Similarly,
micro- and nano-carriers have a potential to get
marginated (Mu¨ller et al., 2014), and therefore
to interact with vessel walls.
The role of particle size and shape in the
efficient delivery is a multi-faceted problem.
Large enough particles with a characteristic
size greater than approximately 4 µm may get
trapped in the smallest capillaries of the body
(Slack et al., 1981). On the other hand, par-
ticles with a size of only a few nanome-
ters are rapidly excreted through the kidneys
(De Jong et al., 2008). Studies with intravas-
cularly injected silica particles with a moder-
ate size (from 700 nm to 3 µm) have shown that
smaller particles yield a more uniform distribu-
tion in various organs in comparison with the
larger ones (Decuzzi et al., 2010). In addition,
an enhanced accumulation of the particles in
the organs has been found for particles having
a discoidal shape (Decuzzi et al., 2010). How-
ever, particle internalization by macrophages
appears to be reduced for elongated particles
(Champion and Mitragotri, 2006). Adhesion
of different particles has been studied experi-
mentally (Gentile et al., 2008) and theoretically
(Decuzzi and Ferrari, 2006); these studies show
that oblate ellipsoids are subject to stronger ad-
hesion than spheres with the same volume. To
better understand adhesive potential of micro-
and nano-carriers, quantitative description of
particle margination under realistic blood flow
conditions is required.
Numerical simulations of blood flow on a
single-cell level allow us to explore the flow be-
havior and interaction of blood cells and other
suspended components (Fedosov et al., 2014b;
Freund, 2014; Fedosov et al., 2014a). In this
work, we investigate the role of particle size
and shape on the margination efficiency, and
therefore adhesion, since particle margination
is an essential pre-condition for particle adhe-
sion (Mu¨ller et al., 2014). Several sizes rang-
ing from several microns to about one hundred
nanometers and two different shapes (spherical
and ellipsoidal) are considered. The margina-
tion of micro- and nano-particles is studied for
a wide range of hematocrit values and flow
rates using mainly two-dimensional (2D) sim-
ulations. Our findings show that spherical par-
ticles have slightly better margination proper-
ties than ellipsoids, however the adhesion ef-
ficiency of ellipsoidal particles appears to be
superior in comparison with that of spheres
due to a larger area for adhesive interactions
(Decuzzi and Ferrari, 2006). The larger par-
ticles possess a larger probability of being
marginated. As the particle size becomes very
small (less than 100 − 200 nm), the particle dis-
tribution within vessel cross-section can be de-
scribed well by the volume excess of flowing
RBCs.
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2 Models and methods
Simulation method. Our simulations are
based on the dissipative particle dynamics
(DPD) method (Hoogerbrugge and Koelman,
1992; Espan˜ol and Warren, 1995), a meso-
scopic particle-based approach which captures
full hydrodynamics. The simulated system is
represented by a collection of point particles
which interact locally through three pairwise
forces: a conservative, dissipative, and random
force. The time evolution of the velocity and
position of the particles is determined by the
Newton’s second law of motion.
Modeling cells and particles. RBCs in 2D
are modeled as closed bead-spring chains of Ns
connected particles, which incorporate bending
rigidity and an area constraint (Fedosov et al.,
2012). Suspended micro- and nano-carriers
are represented by a collection of N
p
v particles,
which are constrained to maintain a rigid con-
figuration.
Simulation setup. The simulated system cor-
responds to a 2D channel with a width of W =
20 µm. Figure 1 displays a simulation snap-
shot for a hematocrit (the area fraction of RBCs)
of Ht = 0.3. The flow is confined by two
walls which are modeled using frozen fluid par-
ticles in combination with a bounce-back re-
flection of flow particles at the fluid-wall inter-
face (Fedosov and Karniadakis, 2009). In flow
direction, periodic boundary conditions are as-
sumed and blood flow is driven by a constant
force applied to each solvent particle, which is
equivalent to a prescribed pressure drop. In or-
der to characterize the flow strength, we define
a non-dimensional shear rate as
γ˙∗ = ¯˙γτRBC = ¯˙γ
ηD3r
κr
, (1)
where ¯˙γ = v¯/W is the average shear rate (or
pseudo shear rate) and v¯ is the average flow ve-
locity, while τRBC defines a characteristic RBC
relaxation time. Here, η is the solvent’s dy-
namic viscosity, Dr = L0/pi is the correspond-
ing RBC diameter with L0 being the cell con-
tour length, and κr is the RBC membrane bend-
ing rigidity. The RBCs are further characterized
by the reduced area A∗ = 4A0/(piD
2
r ) = 0.46,
where A0 is the enclosed RBC area. Typical
values for real healthy RBCs are Dr = 6.1 µm,
η = 1.2 × 10−3 Pa s, and κr = 50kBT for the
physiological temperature T = 37 ◦C.
Measuring RBC-free-layer thickness. To
determine the RBC-free-layer (RBCFL) thick-
ness, we measure the outer edge of the RBC
core, which is similar to RBCFL measurements
in experiments (Maeda et al., 1996; Kim et al.,
2007). The data is averaged for many RBC
snapshots at different times.
(a)
(b)
Figure 1: Snapshots of RBC and particle confor-
mations in microchannels in 3D and 2D. RBCs are
colored in red and suspended particles in blue. (a)
3D simulation snapshot of blood flow for Ht = 0.3
and γ˙∗ ≈ 39. (b) 2D simulation snapshot of blood
flow for Ht = 0.3 and γ˙
∗
≈ 29.3.
3 Results
3.1 Carrier margination
Margination of micro- and nano-carriers in
blood flow depends on hematocrit Ht and flow
rate characterized by γ˙∗ (Mu¨ller et al., 2014).
Numerical simulations performed for different
conditions allow us to measure the distributions
of particles across the flow, which reflect the
probability of a particle to be at a certain ra-
dial position. Figure 2 shows several center-
of-mass distributions of circular particles with
Dp = 0.3Dr (Dp = 1.83 µm) for several Ht
values and γ˙∗ ≈ 29.3. The distributions have
been averaged over the halves of the channel
due to symmetry. The distributions indicate
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that as Ht increases the carriers marginate bet-
ter, since a strong peak in the distributions de-
velops and its position moves closer to the wall
at y/W = 0. This trend is in agreement with
the margination of blood platelets, which have
a comparable size, such that platelet margina-
tion has been observed to increase with in-
creasing Ht in experiments (Tilles and Eckstein,
1987) and simulations (Crowl and Fogelson,
2011; Zhao and Shaqfeh, 2011; Reasor Jr et al.,
2013). The distributions in Fig. 2 also show that
the carriers migrate into the RBCFL near a wall
and remain quasi-trapped there. The shift of the
peak toward the wall is due to a decrease in the
RBCFL thickness as Ht is increased, leading to
a smaller available space for marginated parti-
cles.
Figure 2: Particle distribution across the chan-
nel. Center-of-mass distribution of carriers for vari-
ous Ht values at γ˙
∗
≈ 29.3. 2D simulation results for
circular particles with Dp = 0.3Dr (Dp = 1.83µm).
The wall is at y/W = 0. The shaded area indi-
cates schematically a region with a thickness δ near
the wall. The arrows indicate the boundary of the
RBCFL for the different hematocrits, marked by cor-
responding colors.
To quantify particle margination we define
the margination probability as a probability of
a particle center-of-mass to be within a certain
distance away from the wall. This is sketched
in Fig. 2 with a selected distance of δ = 0.33Dr
(about 2 µm), which is smaller than the RBCFL
thickness in most cases. Other choices for
the distance δ are possible and discussed by
Mu¨ller et al. (2014). Figure 3 presents margina-
tion probability diagram of particles for a wide
range of Ht values and non-dimensional shear
rates. The aforementioned dependence of parti-
cle margination on Ht is observed essentially for
every flow rate. Particle margination also shows
a strong dependence on γ˙∗, which is most pro-
nounced at low shear rates. Simulated values
of γ˙∗ cover the range of flow rates characteristic
for the venular part of microcirculation, where it
is estimated that γ˙∗ . 90 in 3D (γ˙∗ . 77 in 2D),
while in arteriolar part the flow rates are higher
with γ˙∗ & 120 in 3D (Popel and Johnson, 2005;
Pries et al., 1995). This range of shear rates is
also relevant for tumor microvasculature, since
blood flow velocities in tumors are much re-
duced in comparison to those in normal mi-
crovasculature due to high geometric resistance
and vessel permeability (Jain, 1988; Yuan et al.,
1994).
The margination probability diagram in
Fig. 3 shows that the strongest particle margina-
tion is found for the range of Ht = 0.25 − 0.6.
This region has a considerable overlap with
the characteristic hematocrits in the body’s mi-
crovascular networks in the range Ht = 0.2−0.4.
A strong particle margination at high Ht values
seems to be an advantage for drug delivery to
tumors, since blood within tumor microvascula-
ture is often subject to hemo-concentration due
to plasma leakage (Sevick and Jain, 1989).
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Figure 3: Particle margination diagram. Proba-
bility diagram of particle margination with respect
to γ˙∗ and Ht. The white squares indicate the val-
ues of Ht and γ˙
∗ for which simulations have been
performed. The margination probabilities are calcu-
lated from the particle center-of-mass distributions
using a distance of δ = 0.33Dr (2µm) away from the
wall.
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3.2 Dependence of margination on particle
size.
The discussion above considered the margina-
tion effect of micron-size particles, however
there exists a strong interest in nano-carriers
with sizes starting from several nanometers.
Figures 4(a),(b) show the probability diagrams
which characterize margination properties of
particles with Dp = 0.15Dr (Dp = 0.91 µm) and
Dp = 0.04Dr (Dp = 250 nm), respectively. Vi-
sual examination of Fig. 4(a),(b) and Fig. 3
for Dp = 0.3Dr (Dp = 1.83 µm) indicates that
the region of high margination probability be-
comes smaller as the particle size is decreased.
Thus, we can conclude that the margination of
particles worsens as the carrier size becomes
smaller, which is similar to the results found by
Mu¨ller et al. (2014).
To illustrate the reason for the reduction in
particle margination probability with decreas-
ing particle size, we present in Fig. 4(c) the dis-
tributions of particles with different sizes across
the channel for Ht = 0.3 and γ˙
∗
≈ 29.3. For
large enough particles we observe a pronounced
peak in the distribution next to the wall due
their interactions with RBCs leading to parti-
cle quasi-confinement within the RBCFL, since
the particle size is comparable with the RBCFL
thickness. Even though small particles are also
subject to the margination effect, their distribu-
tion within the RBCFL is more uniform and
their presence around the vessel centerline is
slightly more probable than that for larger par-
ticles. Thus, the cumulative probability for a
single particle to be within a layer of thickness
0.33Dr near the wall is lower for nano-carriers
than that for micro-particles. An interesting ob-
servation, however, is that the distribution of the
smallest simulated particles with Dp = 0.04Dr
(Dp = 250 nm) closely approaches the distri-
bution computed as the excess volume of flow-
ing RBCs. This indicates that the distribution
of particles smaller in size than approximately
250 nm can be well approximated by the blood
plasma volume, and therefore their margination
properties can be directly inferred from the lo-
cal Ht distribution.
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Figure 4: Dependence of margination on particle
size. Probability diagrams of particle margination
for various Ht and γ˙
∗ values and for circular particles
with the sizes (a) Dp = 0.15Dr (Dp = 0.91µm), (b)
Dp = 0.04Dr (Dp = 0.25µm). The white squares
indicate the values of Ht and γ˙
∗ for which simula-
tion were performed. The margination probability
is calculated based on the distance of 0.33Dr (2µm)
away from the wall. (c) Distribution of particles with
different sizes across the channel for Ht = 0.3 and
γ˙∗ ≈ 29.3. For small particles the distribution re-
sembles the curve computed as the excess RBC vol-
ume and drawn by black solid line. The arrow de-
notes position of the RBCFL boundary.
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3.3 Dependence of margination on particle
shape.
Advances in micro- and nano-particle fab-
rication allow the production of carriers in
various shapes, including a sphere, ellip-
soid, and a rod-like shapes (Rolland et al.,
2005). However, advantages of differ-
ent particle shapes for drug delivery are
still not well explored. Recent theoreti-
cal (Decuzzi and Ferrari, 2006; Dasgupta et al.,
2013) and experimental (Gentile et al., 2008)
studies suggest that ellipsoidal particles possess
better adhesion properties than spheres due to
a larger area for adhesion interactions. To ex-
plore the effect of particle shape on the margina-
tion properties in blood flow, we performed a
number of simulations with ellipse-shaped par-
ticles. Figure 5 shows the margination prob-
ability diagram for an ellipse-like particle un-
der various blood flow conditions. The ellipse
has an aspect ratio of about 7. The ellipse area
corresponds to the area of a circle with the di-
ameter Dp = 0.22Dr, so that the comparison
of the margination diagram in Fig. 5 can be
best made with those in Figs. 3 and 4(a). Vi-
sual inspection of the margination probability
diagrams for spherical and ellipsoidal particles
indicates that the corresponding diagrams are
qualitatively similar. A quantitative analysis
shows that the margination of ellipsoidal par-
ticles appears to be slightly less efficient than
that of spheres; however, the differences are not
very significant. Note that these findings also
indicate that ellipsoidal particles with a smaller
aspect ratio than 7 have margination properties
similar to those presented in Figs. 3 and 5. In
conclusion, the current knowledge about adhe-
sion of ellipsoidal particles and our simulation
results on margination suggest that ellipsoidal
particles are likely to be a better choice for drug
delivery.
4 Summary
In summary, particle margination in blood
flow strongly depends on particle size and
shape, hematocrit, and flow rate. Margination
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Figure 5: Dependence of margination on particle
shape. Probability diagram of particle margination
for various Ht and γ˙
∗ values and for the ellipse-like
particles. The long axis of a 2D elliptic particle is
Lp = 0.63Dr (3.84µm) and an aspect ratio is equal
to approximately 7. The white squares indicate the
values of Ht and γ˙
∗ for which simulation were per-
formed. The margination probability is calculated
based on the distance of 0.33Dr away from the wall.
of both spherical and ellipsoidal particles in-
creases with increasing hematocrit, while their
margination properties appear to be rather simi-
lar, where a sphere marginates slightly more ef-
ficiently than an ellipsoid. The presented dia-
grams show that larger particles have a higher
margination probability in comparison to the
smaller ones. Moreover, the distribution of very
small particles with a diameter smaller than ap-
proximately 250 nm is well represented by the
excess volume of RBCs (blood plasma volume).
In conclusion, our results suggest that an ellip-
soidal shape of carriers with a micron rather
than sub-micron size is likely to be favorable
for drug delivery.
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